Guidance for WuXi PharmaTech (WX)
| Period |
Range |
Estimate |
Revenue Range |
Revenue Estimate |
Target |
Details |
| 2013 |
$1.49 – 1.53 |
$1.44 |
$565.00M – 575.00M |
$571.58M |
= Maintained |
Details |
| Q2 2013 |
$0.39 – 0.40 |
$0.36 |
$138.00M – 140.00M |
$142.30M |
= Maintained |
Details |
| 2012 |
N/A |
N/A |
$488.00M – 498.00M |
$484.30M |
 Raised |
Details |
| 2012 |
N/A |
N/A |
$495.00M – 498.00M |
$485.00M |
Raised |
Details |
| 2012 |
N/A |
N/A |
$468.00M – 488.00M |
$464.60M |
= Maintained |
Details |
| Q4 2012 |
N/A |
N/A |
$121.00M – 124.00M |
$119.73M |
= Maintained |
Details |
| Q3 2012 |
N/A |
N/A |
$121.00M – 124.00M |
$119.73M |
= Maintained |
Details |
| Q2 2012 |
N/A |
N/A |
$124.00M – 129.00M |
$118.03M |
= Maintained |
Details |
| Q1 2012 |
N/A |
N/A |
$114.00M – 117.00M |
$108.00M |
= Maintained |
Details |
| 2011 |
N/A |
N/A |
$400.00M – 407.00M |
$400.89M |
= Maintained |
Details |
| 2011 |
N/A |
N/A |
$402.00M – 406.00M |
$405.23M |
= Maintained |
Details |
| 2011 |
N/A |
N/A |
$390.00M – 405.00M |
$395.52M |
= Maintained |
Details |
| Q3 2011 |
N/A |
N/A |
$100.00M – 103.00M |
$101.17M |
= Maintained |
Details |
| Q2 2011 |
N/A |
N/A |
$97.00M – 99.00M |
$99.10M |
= Maintained |
Details |
